InsiderTrades

Form 4 for IRMD IRADIMED CORP

Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-11 · accession 0002047489-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-12 2025-12-11 IRMD Chiprin Jeff Chief Commercial Off F - Tax $97.38 -309 687 -31% -$30.1K
D 2025-12-12 2025-12-11 IRMD Chiprin Jeff Chief Commercial Off M - OptEx — +996 996 New —
D 2025-12-12 2025-12-11 IRMD Chiprin Jeff Chief Commercial Off M - OptEx $0.00 -996 1,994 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-11 F D 309 $97.38 687 D — —
2 Common Common Stock 2025-12-11 M A 996 — 996 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2025-12-11 M D 996 $0.00 1,994 D — · — to — 996 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.